As the US’ mass COVID-19 vaccination campaign continues at a record pace, one question under debate is what the administration of US President Joe Biden should do with its extra doses — and especially where to send them.
One country that should be at the top of a donation list is Taiwan, in recognition of the help that it provided to the US at the outset of the COVID-19 pandemic last year.
After weeks of pressure, the Biden administration announced that it is now “looking at options to share American-made AstraZeneca vaccine doses.”
By summer, it is clear that anyone in the US who wants a vaccine would have received one. The US government has purchased 300 million doses each of the Pfizer-BioNTech and Moderna vaccines — enough for 300 million people — plus tens of millions of doses of the AstraZeneca vaccine that are sitting in storage waiting for approval.
Taiwan — which set a gold standard for its COVID-19 response with fewer than 1,200 cases — has been slow to receive and administer vaccine doses. While Taiwan has ordered about 20 million doses from suppliers, more than 58,000 people, mostly healthcare workers, have received at least one dose.
The slow rate is attributed to doubts over the AstraZeneca vaccine’s safety, potentially leading to their expiration by the end of this month if not used.
Considering the danger of the many virus variants surging around the globe, the administration of President Tsai Ing-wen (蔡英文) should work to bolster public receptiveness to whatever vaccines are available. Taiwan has made it this far in the pandemic; it would a shame for a lapse to occur due to vaccine hesitancy.
The slow pace at which Taiwan is receiving COVID-19 vaccines is nothing particularly unique. Countries around the globe are not receiving what they paid for and are having to lower their vaccination goals as a result.
However, Taiwan has faced another, unique set of vaccine issues related to Chinese interference. Taipei has encountered issues in its effort to acquire 5 million doses of the Pfizer-BioNTech vaccine, and has blamed Beijing for meddling in the process. The doses would be manufactured in Shanghai, so Beijing can exert some influence in this regard.
Taiwan’s unique geopolitical position allows China to pressure companies to spurn it. Beijing has not shied away from using its economic heft to get countries and private corporations to follow its line with regards to Taiwan.
It has worked on clothing companies and airlines, and now that strategy has worked on pharmaceutical companies.
Given Taiwan’s difficulties, the Biden administration should help the nation. When the US had massive personal protective equipment (PPE) shortages at the beginning of the pandemic last year, Taiwan donated millions of masks.
Taiwan has donated more than 30 million surgical masks to countries around the world, including more than 12 million to the US through its “Taiwan can help” campaign. Those donations still continue one year later.
At a time when US healthcare workers were using trash bags and bandanas for protection, Taiwan provided much-needed PPE. Those masks no doubt saved the lives of healthcare workers at a critical juncture.
The US owes Taiwan a debt for these PPE donations. The best way for Washington to repay this debt is to provide Taiwan with something that it could use right now: vaccine doses.
Such a gesture would also reward the proper way to help those in need — a stark contrast to how Beijing carried out a similar donation campaign. As Taipei was quietly donating PPE around the world, Beijing pushed countries to express public praise and thanks for receiving donations from China. Some of those donations proved to be defective.
The difference in approach between Taipei and Beijing has continued into this year with vaccine acquisition. China reportedly pressured Paraguay into switching diplomatic relations from Taiwan to China in exchange for millions of Chinese COVID-19 vaccines.
Taiwan worked with India, which provided Paraguay with 100,000 doses. By working with India to provide Paraguay with vaccines, Taiwan showed that it can work with other partners to help countries in need.
Taiwan has its own vaccines in trials. If approved, they could be ready for mass production by July. A best-case scenario would be for Washington to help Taipei complete its domestic vaccination efforts before a Taiwanese vaccine is ready — thus freeing up another vaccine for use in countries struggling to contain the pandemic.
Instead of working with India — which is facing a terrifying surge in COVID-19 cases and related PPE shortages — to provide doses, Taiwan could become another trusted vaccine provider to other countries finding it difficult to acquire them.
As the pandemic worsens around the globe, having another vaccine ready for distribution would be another example of Taiwan helping countries in need.
While Taipei cannot expect countries to switch diplomatic relations, a strong soft power campaign centered around no-strings-attached PPE and vaccine donations could help strengthen informal ties and potentially create an even better case for participation in international organizations.
Taiwan has proven itself to be a reliable partner for the US, despite its geopolitical limitations.
The Biden administration has expressed strong support for Taiwan in its initial months, most recently by sending an unofficial delegation to Taipei to provide a “personal signal” of Biden’s support. Its initial signals and messages are a great first step as the administration begins to set its policy agenda.
When healthcare workers in the US and around the globe needed PPE, Taiwan stepped up. Now, the US has an abundance of vaccines. The Biden administration should return the favor by providing Taiwan with some of its excess doses.
Thomas Shattuck is a research fellow in the Asia Program at the Foreign Policy Research Institute. He is also a member of Foreign Policy for America’s NextGen Foreign Policy Initiative.
In the US’ National Security Strategy (NSS) report released last month, US President Donald Trump offered his interpretation of the Monroe Doctrine. The “Trump Corollary,” presented on page 15, is a distinctly aggressive rebranding of the more than 200-year-old foreign policy position. Beyond reasserting the sovereignty of the western hemisphere against foreign intervention, the document centers on energy and strategic assets, and attempts to redraw the map of the geopolitical landscape more broadly. It is clear that Trump no longer sees the western hemisphere as a peaceful backyard, but rather as the frontier of a new Cold War. In particular,
When it became clear that the world was entering a new era with a radical change in the US’ global stance in US President Donald Trump’s second term, many in Taiwan were concerned about what this meant for the nation’s defense against China. Instability and disruption are dangerous. Chaos introduces unknowns. There was a sense that the Chinese Nationalist Party (KMT) might have a point with its tendency not to trust the US. The world order is certainly changing, but concerns about the implications for Taiwan of this disruption left many blind to how the same forces might also weaken
As the Chinese People’s Liberation Army (PLA) races toward its 2027 modernization goals, most analysts fixate on ship counts, missile ranges and artificial intelligence. Those metrics matter — but they obscure a deeper vulnerability. The true future of the PLA, and by extension Taiwan’s security, might hinge less on hardware than on whether the Chinese Communist Party (CCP) can preserve ideological loyalty inside its own armed forces. Iran’s 1979 revolution demonstrated how even a technologically advanced military can collapse when the social environment surrounding it shifts. That lesson has renewed relevance as fresh unrest shakes Iran today — and it should
As the new year dawns, Taiwan faces a range of external uncertainties that could impact the safety and prosperity of its people and reverberate in its politics. Here are a few key questions that could spill over into Taiwan in the year ahead. WILL THE AI BUBBLE POP? The global AI boom supported Taiwan’s significant economic expansion in 2025. Taiwan’s economy grew over 7 percent and set records for exports, imports, and trade surplus. There is a brewing debate among investors about whether the AI boom will carry forward into 2026. Skeptics warn that AI-led global equity markets are overvalued and overleveraged
RSS